[Federal Register: December 31, 2002 (Volume 67, Number 251)]
[Notices]
[Page 79943]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr31de02-72]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Clinical Center; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of a meeting of
the Board of Governors of the Warren Grant Magnuson Clinical Center.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended
for discussion of personal qualifications and performance, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Governors of the Warren Grant
Magnuson Clinical Center.
Date: January 27, 2003.
Open: 9 a.m. to 11 a.m.
Agenda: For discussion of programmatic policies and issues.
Place: National Institutes of Health, Clinical Center, 9000
Rockville Pike, Bethesda, MD 20892.
Closed: 11 a.m. to 12 p.m.
Agenda: To review and evaluate personnel qualifications.
Place: National Institutes of Health, Clinical Center, 9000
Rockville Pike, Bethesda, MD 20892.
Contact Person: Maureen E. Gormley, Executive Secretary, Warren
Grant Magnuson Clinical Center, National Institutes of Health,
Building 10, Room 2C146, Bethesda, MD 20892, 301/496-2897.
Information is also available on the Institute's/Center's home
page: http://www.cc.nih.gov/, where an agenda and any additional
information for the meeting will be posted when available.
Dated: December 20, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
FR Doc. 02-33028 Filed 12-30-02; 8:45 am]
BILLING CODE 4140-01-M
[Federal Register: December 31, 2002 (Volume 67, Number 251)]
[Notices]
[Page 79943]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr31de02-73]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of a meeting of
the Secretary's Advisory committee on Xenotransplantation (SACX).
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting
Name of Committee: Secretary's Advisory Committee on
Xenotransplantation.
Date: February 3-4, 2003.
Open: February 3, 2003; 8:30 a.m. to 6:30 p.m., February 4,
2003; 8 a.m. to 3 p.m.
Agenda: The SACX will focus on a variety of issues relating to
the science and ethics of xenotransplantation. A significant portion
of the meeting will be devoted to discussion of two draft reports by
the SACX. These draft reports address the state of the science in
xenotransplantation and informed consent issues in
xenotransplantation. Additional presentations and discussion will
focus on results from animal models of xenotransplantation.
Place: Holiday Inn Select, 8120 Wisconsin Avenue, Bethesda MD
20814.
Pre-Registration: The SACX meeting is open to the public;
however, seating is limited and pre-registration is encouraged. To
pre-registration, please contact Capital Consulting Corporation
(Terry Fisher) at 301-468-6004, extension 434. Individuals who plan
to attend the meeting and who need special assistance or other
reasonable accommodations should notify Ms. Fisher prior to the
meeting.
Public Comment: Individuals who wish to provide comment (oral or
written) should contact the SACX Executive Director, Dr. Mary
Groesch, by telephone at 301-496-0785 or e-mail at
groeschm@od.nih.gov.
Contact Person: Mary Groesch, PhD, Executive Director,
Secretary's Advisory Committee on Xenotransplantation, Office of
Science Policy, Rockledge I, Room 750, Bethesda MD 20892, 301-496-
9838.
Information is also available on the Office's home page:
http:www4.od.nih.gov/oba/Sacx/.htm, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.187, Undergraduate
Scholarship Program for Individuals from Disadvantaged Backgrounds;
93.22, Clinical Research Loan Repayment Program for Individuals from
Disadvantaged Backgrounds; 93.232, Loan Repayment Program for
Research Generally; 93.39, Academic Research Enhancement Award;
93.936, NIH Acquired Immunodeficiency Syndrome Research Loan
Repayment Program, National Institutes of Health, HHS)
Dated: December 23, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-33030 Filed 12-30-02; 8:45 am]
BILLING CODE 4140-01-M